109 related articles for article (PubMed ID: 11861367)
1. Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells.
Burg MA; Jensen-Pergakes K; Gonzalez AM; Ravey P; Baird A; Larocca D
Cancer Res; 2002 Feb; 62(4):977-81. PubMed ID: 11861367
[TBL] [Abstract][Full Text] [Related]
2. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.
Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C
Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229
[TBL] [Abstract][Full Text] [Related]
3. Better gene expression by (-)gene than by (+)gene in phage gene delivery systems.
Liang Y; Shi B; Zhang J; Jiang H; Xu Y; Li Z; Gu J
Biotechnol Prog; 2006; 22(3):626-30. PubMed ID: 16739942
[TBL] [Abstract][Full Text] [Related]
4. Receptor-targeted gene delivery using multivalent phagemid particles.
Larocca D; Jensen-Pergakes K; Burg MA; Baird A
Mol Ther; 2001 Apr; 3(4):476-84. PubMed ID: 11319907
[TBL] [Abstract][Full Text] [Related]
5. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
[TBL] [Abstract][Full Text] [Related]
6. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
8. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
[TBL] [Abstract][Full Text] [Related]
9. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
[TBL] [Abstract][Full Text] [Related]
10. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.
Kanazawa T; Mizukami H; Okada T; Hanazono Y; Kume A; Nishino H; Takeuchi K; Kitamura K; Ichimura K; Ozawa K
Gene Ther; 2003 Jan; 10(1):51-8. PubMed ID: 12525837
[TBL] [Abstract][Full Text] [Related]
11. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
Nivens MC; Felder T; Galloway AH; Pena MM; Pouliot JJ; Spencer HT
Cancer Chemother Pharmacol; 2004 Feb; 53(2):107-15. PubMed ID: 14605862
[TBL] [Abstract][Full Text] [Related]
12. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
13. Development of efficient RNA interference system using EGF-displaying phagemid particles.
Jiang H; Cai XM; Shi BZ; Zhang J; Li ZH; Gu JR
Acta Pharmacol Sin; 2008 Apr; 29(4):437-42. PubMed ID: 18358089
[TBL] [Abstract][Full Text] [Related]
14. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
15. Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells.
Kassner PD; Burg MA; Baird A; Larocca D
Biochem Biophys Res Commun; 1999 Nov; 264(3):921-8. PubMed ID: 10544031
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
Trofimova I; Dimtchev A; Jung M; Rosenthal D; Smulson M; Dritschilo A; Soldatenkov V
Cancer Res; 2002 Dec; 62(23):6879-83. PubMed ID: 12460902
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts.
Gao ZN; Wei YQ; Yang PS; Xu X; Zhao HQ; Huan X; Kang B
Oral Oncol; 2007 May; 43(5):477-83. PubMed ID: 16997614
[TBL] [Abstract][Full Text] [Related]
19. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
[TBL] [Abstract][Full Text] [Related]
20. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
